Laboratory Studies in Breast Implant Patients: ANA Positivity, Gammaglobulin Levels, and Other Autoantibodies

  • R. I. Lewy
  • E. Ezrailson
Conference paper
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 210)


SILICONE induced connective tissue disease has been anecdotally but heavily documented over the past 20 years soon beginning after the introduction of the substance for prosthetic use [1–16].Other syndromes reported include synovitis, adenopathy, splenomegaly, systemic sclerosis, granuloma formation, and possible carcinogenesis.


Systemic Lupus Erythematosus Chronic Fatigue Syndrome Connective Tissue Disease Antinuclear Antibody Breast Implant 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Brown, JB, Fryer MP, David A. (1960).Study and use of synthetic materials such as silicone and teflon as subcutaneous protheses. Plastic and Reconstruct Surg. 26:264–27.CrossRefGoogle Scholar
  2. 2.
    Endo LP, Edwards NL, Longley S, Cormann LC, Panush RS. (1987).Silicone and rheumatic diseases. Semin Arthritis Rheum 17:112–118.PubMedCrossRefGoogle Scholar
  3. 3.
    Fock KM, Feng PH, Tey B.(1984). Autoimmune disease developing after augmentation mammoplasty: report of 3 cases. J Rheumatol 11:98–100.PubMedGoogle Scholar
  4. 4.
    Goldblum RM, Pelley RP, O’Donnell AA, Pyron D, Heggers JP (1992). Antibodies to silicone elastomers and reactions to ventribuloperitoneal shunts. Lancet; 340:510–513.PubMedCrossRefGoogle Scholar
  5. 5.
    Heggers JP, Kossovsky N, Parson RW, Robson MC, Pelley RC, Talmage RJ.(1983). Biocompatibility of silicone implants. Ann Plastic Surg 11:38–45CrossRefGoogle Scholar
  6. 6.
    Kaiser W, Biesenback, Stuby U, Grafinger P, Zazgornik J (1990). Human adjuvant disease: remission of silicone-induced autoimmune disease after explanation of breast augmentation. Ann Rheum Dis 49:937–938.PubMedCrossRefGoogle Scholar
  7. 7.
    Kossovsky N, Heggers JP, Robson MC. (1987).Experimental demonstration of the immunogenicity of silicone-protein complexes. J Biomed Mater Res 21:1125–33.PubMedCrossRefGoogle Scholar
  8. 8.
    Okano V, Nishikai M, Sato A. (1984).Scleroderma, primary biliary cirrhosis and Sjogren’s syndrome after cosmetic breast augmentation with silicone injection: a case report of possible human adjuvant disease. Ann Rheum Dis 43:520–1.PubMedCrossRefGoogle Scholar
  9. 9.
    Peimer CA, Medige J, Eckert BS, Wright JR, Howard CS (1986). Reactive synovitis after silicone arthroplasty. H Hand Surg IIA:624–38.Google Scholar
  10. 10.
    Sergott TJ, Limoli JP, Baldwin CM Jr, Laub DR.(1986). Human adjuvant disease, possible autoimmune disease after silicone implantation: a review of the literature, case studies, and speculation for the future. Plast Reconstr Surg 78:104–14PubMedCrossRefGoogle Scholar
  11. 11.
    Silverstein MJ, Handel N, Gamagami P, Gierson ED, Furmanski M, Collins AR, Epstein M, Cohlan BF.(1992). Breast cancer diagnosis and prognosis in women following augmentation with silicone gel-filled prostheses. Eur J Cancer 1992; 28-635–640PubMedCrossRefGoogle Scholar
  12. 12.
    Spiera H. (1988).Scleroderma after silicone augmentation mammoplasty. JAMA 260:236–8.PubMedCrossRefGoogle Scholar
  13. 13.
    van Nunen SA, Gatenby PA, Basten A.(1983). Post-mammoplasty connective tissue disease. Arthritis Rheum 25:294–7.Google Scholar
  14. 14.
    Varga J, Jimenez SA. (1990).Augmentation mammoplasty and scleroderma. Is there an association? Arch Dermatol 126:1220–1221PubMedCrossRefGoogle Scholar
  15. 15.
    Varga J, Schumacher HR, Jimenez SA. (1989).Systemic sclerosis after augmentation mammoplasty with silicone implants. Ann Intern Med 111:377–83.PubMedGoogle Scholar
  16. 16.
    Yoshida K.(1973). Post mammoplasty disorder as an adjuvant disease of man. Shikoku Acta Med 29:318–32.Google Scholar
  17. 17.
    Sontheimer RD, McCauliffe DP,et al. (1992) Antinuclear Antibodies: Clinical Correlations and Biological Significance. Adv Dermat.7:3–52Google Scholar
  18. 18.
    Lipscomb MF, Cope LD, Stephens GL, et al.(1984) Comparison of substrates for the Detection of Antinuclear Antibodies in Normals and In Patients with Connective Tissue Disease and Other Diseases. Diagn Immunol 2:181–187.PubMedGoogle Scholar
  19. 19.
    Anderson P.(1977). Correlation of amooth muscle and nuclear antibodies in normal subjects. Clin Exp Med 27:74–77.Google Scholar
  20. 20.
    Borak J, Vasey F, Lauter S et al.(1979). Immunofluorescence Assay for Antinuclear Factor: A Non-specific Test in Hospitalized Patients. Can Med J 121:1372–1374.Google Scholar
  21. 21.
    Shu S, Nidengard RJ, Hale WL et al (1975).Incidence and titers of Antinuclear Antismooth muscle and other autoantibodies in blood donors. J Lab Clin Med 86,259–265.PubMedGoogle Scholar
  22. 22.
    Carsons S.( 1988).Newer laboratory parameters for the diagnosis of rheumatic disease. Am J Med 85(4A): 34–8Google Scholar
  23. 23.
    Shiel WC, Jason M.(1989) The Diagnostic Association of Patients with Antinuclear Antibodies Referred to a Community Rheumatologist. J Rheumatol. 91:249–255.Google Scholar
  24. 24.
    Smeenk RJ, van den Brink HG, Brinkman K, Termaat RM, Berden JH, Swaak AJ.(1991) Anti-dsDNA: choice of assay in relation to clinical value. Rheumatol Int 11(3): 101–7.PubMedCrossRefGoogle Scholar
  25. 25.
    Tan EM.(1989).Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 93–151Google Scholar
  26. 26.
    De Vlam, K, De Keyser F, Verbruggen M. Et al.(1993). Detection and Identification of Antinuclear Antibodies in the Serum of Normal Blood Donors. Cliinical and Experimental Rheumatology 11:393–397.Google Scholar
  27. 27.
    Guilbert B, Dighiero G, Avrameas S. (1982). Naturally Occurring Antibodies Against Nine Common Antigens in Human Sera. J Immunol 128:2279–2287.Google Scholar
  28. 28.
    Segal R, Globerson A, Singer H et al.(1992) The Influence of Aging on the Induction and Manifestations of Experimental Systemic Lupus Erythematosus. J Clin Immunol. 12:5.341-346.CrossRefGoogle Scholar
  29. 29.
    Spiera H, Kerr LD.(1993).Scleroderma following silicone implantation: a cumulative experience of 11 cases. J Rheumatol 20(6): 958–61.PubMedGoogle Scholar
  30. 30.
    Sahn EE, Garen PD, Silver RM, Maize JC.(1990).Scleroderma following augmentation mammoplasty. Report of a case and review of the literature [see comments] Arch Dermatol 126(9): 1198–202.PubMedCrossRefGoogle Scholar
  31. 31.
    Gutierrez FJ, Espinoza LR.(1990).Progressive systemic sclerosis complicated by severe hypertension: reversal after silicone implant removal. Am J Med 89(3): 390–2.PubMedCrossRefGoogle Scholar
  32. 32.
    Press Rl, Peebles CL, Kumagai Y, Ochs RL, Tan EM.(1992).Antinuclear autoantibodies in women with silicone breast implants. Lancet 340(8831): 1304–7.PubMedCrossRefGoogle Scholar
  33. 33.
    Bridges AJ.(1994) Autoantibodies in patients with silicone implants. Semin Arthritis Rheum 24(1 Sup54-60): 54–60.Google Scholar
  34. 34.
    Bridges AJ, Conley C, Wang G, Burns DE, Vasey FB.(1993).A clinical and immunologic evaluation of women with silicone breast implants and symptoms of rheumatic disease [see comments] Ann Intern Med 118(12): 29–36.Google Scholar
  35. 35.
    Claman H,. Robertson AD. (1994).Antinuclear Antibodies and Breast Implants. West J Med. 160:225–228.PubMedGoogle Scholar
  36. 36.
    Coleman, EA, Lemon SJ, Rudick J et al.(1994).Rheumatic Disease Among 1167 Women Reporting Local Implant and Systemic Problems After Breast Implant Surgery. Journal of Women’s Health. 3(3): 165–177.CrossRefGoogle Scholar
  37. 37.
    Wolf LE, Lappe M, Peterson RD, Ezrailson EG.(1993).Human immune response to polydimethylsiloxane (silicone): screening studies in a breast Implant population. FASEB J 7(13): 1265–8.PubMedGoogle Scholar
  38. 38.
    Teuber SS, Rowley MJ, Yoshida SH, Ansari AA, Gershwin ME.(1993).Anti-collagen autoantibodies are found in women with silicone breast implants. J Autoimmun 6(3): 367–77.PubMedCrossRefGoogle Scholar
  39. 39.
    Schusterman MA, Kroll SS, Reece GP, Miller MJ, Ainslie N, Halabi S, Batch CM.(1993).Incidence of autoimmune disease in patients after breast reconstruction with silicone gel implants versus autogenous tissue: a preliminary report. Ann Plast Surg 31(1): 1–6.PubMedGoogle Scholar
  40. 40.
    Gabriel S, O’Fallon WM, Kurland L et al. (1994).Risk of Connective Tissue Diseases and Other Disorders After Breast Implantation. Nejm 330(24): 1697–1702.PubMedCrossRefGoogle Scholar
  41. 41.
    Chang YH.(1993). Adjuvanticity and arthritogenicity of silicone. Plast Reconstr Surg 92(3): 469–73.Google Scholar
  42. 42.
    Clayton D and Hills M. (1993). Statistical Methods in Epidemiology. New York, Oxford Press. 53–62.Google Scholar
  43. 43.
    Brestow NE, Day NE.(1980). Statistical Methods in Cancer Research.Vol 1-the analysis of case-control studies. IARC Scientific Publications No 32. Lyon, International Agency for Research on Cancer, 146–154.Google Scholar
  44. 44.
    Kossovsky N, Zeidler M, Chun G et al.(1993). Surface Dependent Antigens Identified by High Binding Avidity of Serum Antibodies in a Subpopulation of Patients with Breast Prostheses. J of Appl. Biomat 4:281–288.CrossRefGoogle Scholar
  45. 45.
    Garrido L, Pfeiderer B, Papisov M et al.(1993). In vivo degradation of silicones. Magn Res Med 29(6):839–843.CrossRefGoogle Scholar
  46. 46.
    Swaak AJ, Huysen V, Nossent JC, Smeenk RJ. (1990).Antinuclear antibody profiles in relation to specific disease manifestations of systemic lupus erythematosus. Clin Rheumatol 9(1 Sup82-94): 82–94.PubMedCrossRefGoogle Scholar
  47. 47.
    Winfield JB, Jarjour WN. (1991).Stress Proteins, Autoimmunity and Autoimmune Disease. CurrTop Microbiol Immunol 167:161–189.CrossRefGoogle Scholar
  48. 48.
    Weiss NL, Phillips MR, Sadock VA et al.(1990). False positive seroreactivity to Borrelia burgdorferi in rheumatic disease: the value of immunoblot analysis. Clinical Research 38:277A.Google Scholar
  49. 49.
    Yoshida SH, Teuber SS, Gerrman JB et al. (1994). Immunotoxicity of Silicone: Implications of Oxidant Balance Towards Adjuvant Activity. Fd Chem Toxic. 32:1089–1100.CrossRefGoogle Scholar
  50. 50.
    Yoshida SH, German JB, Fletcher MP et al.(1994). The toxic oil syndrome: a perspective on immunotoxicological mechanisms. Regulatory Toxicology and Pharmacology 19:60–79.PubMedCrossRefGoogle Scholar
  51. 51.
    Heggers JP. (1994). Immunogenic Potential of Silicones and Subsequent Clinical Implications. Problems in General Surgery. 11(2): June, 1994.Google Scholar
  52. 52.
    Lappe MA. (1993). Silicone-Reactive Disorder: A New Autoimmune Disease Caused by Immunostimulation and Superantigens. 1993. Medical Hypotheses 41:348–352.PubMedCrossRefGoogle Scholar
  53. 53.
    Drake CG, Kotzin BL. (1992). Superantigens: biology, immunology and potential role in disease. J Clin Immunol 12:149–162.PubMedCrossRefGoogle Scholar
  54. 54.
    Quinlan T, Spivack S, Mossman BT. (1994). Regulation of Antioxidant Enzymes in Lung after Oxidant Activity. Environmental Health Perspectives 102:79–87, 1994.PubMedGoogle Scholar
  55. 55.
    Morse J, Spiera H. (1992). Autoimmune Diseases, Immunoglobulin isotypes, and lymphocyte subsets in 30 females with breast augmentation mammoplasty. J Rheum:S65:185.Google Scholar
  56. 56.
    Barun WF. (1992). HLA molecules in autoimmune diseases. Clin Biochem 25:187–191.CrossRefGoogle Scholar
  57. 57.
    Fox Rl, Holl Kang. (1992). Genetic and Environmental Factors in Systemic Sclerosis. Curr Opin in Rheum 4:875–861.Google Scholar
  58. 58.
    Pilbrant A and Strindberg B. (1975).Pharmacokinetics of 2,6-cis-Diphenylhexamethylcyclotetrasiloxane in Man. Acta Pharm et Tox 36:suppl 3, 139–145.Google Scholar
  59. 59.
    Smalley DL. Puckett DH. Osborne SH et al.(1994). Immunologic Stimulation of Lymphocytes in Silicone Gel Breast Implant Patients. Abstract 7th Annual Meeting of the Association of Medical Laboratory lmmunologists, Boston, Mass. July 14.Google Scholar
  60. 60.
    Ojo-Amaize E A, Conte V, Lin H et al.(1994). Silicone-Specific Blood Lymphocyte Response in Women with Silicone Breast Implants. Clin Diag. Lab Immunol: 1(6):698–695.Google Scholar
  61. 61.
    Potter M, Morrison S, Wiener F, et al.(1994). Induction of Plasmacytomas with Silicone Gel in Genetically Susceptible Strains of Mice. J Nat Canc Inst 86(14):1058–1065.CrossRefGoogle Scholar
  62. 62.
    Naim JO, Lanzafame RJ, van Oss CJ.(1993). Adjuvant effect of silicone-gel on antibody formation in rats. Immunol Invest 22(2): 151–61PubMedCrossRefGoogle Scholar
  63. 63.
    Shoaib B, Patten BM and Calkins DS. (1994).Adjuvant Breast Disease.An Evaluation of 100 Symptomatic Women with Breast Implants or Silicone Fluid Injections. Keio J Med 43(2):79–87.PubMedCrossRefGoogle Scholar
  64. 64.
    Lewy, R.I.(1994). Auto immune Markers and Imaging Abnormalities in Silicone Breast Implant Users. Clinical Research, 42(2), 275A.Google Scholar
  65. 65.
    Lewy, R.I.(1994). Autoimmune Disease and Collagen Dermal Implants. Annals of Internal Medicine, 120(6), 524–525.Google Scholar
  66. 66.
    Komaroff AL.(1988).Chronic fatigue syndromes: relationship to chronic viral infections. J Virol Methods 21(1-4): 3–10Google Scholar
  67. 67.
    Solomon GA.(1994). Clinical and Laboratory Profile of Symptomatic Women with Silicone Breast Implants. Sem Arth Rheum 24(1)Suppl 29–37.Google Scholar
  68. 68.
    Freundlich B, Aitman C, Sandorf N et al.(1994). A Profile of Symptomatic Patients with Silicone Breast Implants: A Sjogren’s-like Syndrome. Sem Arth Rheum 24(1) Suppl 44–53.CrossRefGoogle Scholar
  69. 69.
    Borenstein D et al.(1994). Siliconosis: A Spectrum of Illness. Sem Arth Rheum 24(1) Suppl 1–7.CrossRefGoogle Scholar
  70. 70.
    Vasey FB, Havice DL, Bocanegra TS et al. (1994).Clinical Findings in Symptomatic Women with Silicone Breast Implants. Sem Arth Rheum 24(1) Suppl 22–28.CrossRefGoogle Scholar
  71. 71.
    Lewy Rl.(1995) Antinuclear Antibodies, Lipid Disturbances and Central Nervous System Imaging Abnormalities in Silicone Breast Implant Users. Journal of Investigative Medicine 43:333A.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • R. I. Lewy
    • 1
  • E. Ezrailson
    • 2
  1. 1.Baylor College of Medicine and University of Texas Health Science Center at HoustonUSA
  2. 2.Emerald Biomedical Sciences, Inc.The WoodlandsUSA

Personalised recommendations